» Articles » PMID: 25854580

Data Analysis As a Source of Variability of the HLA-peptide Multimer Assay: from Manual Gating to Automated Recognition of Cell Clusters

Abstract

Multiparameter flow cytometry is an indispensable method for assessing antigen-specific T cells in basic research and cancer immunotherapy. Proficiency panels have shown that cell sample processing, test protocols and data analysis may all contribute to the variability of the results obtained by laboratories performing ex vivo T cell immune monitoring. In particular, analysis currently relies on a manual, step-by-step strategy employing serial gating decisions based on visual inspection of one- or two-dimensional plots. It is therefore operator dependent and subjective. In the context of continuing efforts to support inter-laboratory T cell assay harmonization, the CIMT Immunoguiding Program organized its third proficiency panel dedicated to the detection of antigen-specific CD8(+) T cells by HLA-peptide multimer staining. We first assessed the contribution of manual data analysis to the variability of reported T cell frequencies within a group of laboratories staining and analyzing the same cell samples with their own reagents and protocols. The results show that data analysis is a source of variation in the multimer assay outcome. To evaluate whether an automated analysis approach can reduce variability of proficiency panel data, we used a hierarchical statistical mixture model to identify cell clusters. Challenges for automated analysis were the need to process non-standardized data sets from multiple centers, and the fact that the antigen-specific cell frequencies were very low in most samples. We show that this automated method can circumvent difficulties inherent to manual gating strategies and is broadly applicable for experiments performed with heterogeneous protocols and reagents.

Citing Articles

Unsupervised Analysis of Flow Cytometry Data in a Clinical Setting Captures Cell Diversity and Allows Population Discovery.

Baumgaertner P, Sankar M, Herrera F, Benedetti F, Barras D, Thierry A Front Immunol. 2021; 12:633910.

PMID: 33995353 PMC: 8119773. DOI: 10.3389/fimmu.2021.633910.


Society for Immunotherapy of Cancer clinical and biomarkers data sharing resource document: Volume II-practical challenges.

Cesano A, Cannarile M, Gnjatic S, Gomes B, Guinney J, Karanikas V J Immunother Cancer. 2020; 8(2).

PMID: 33323463 PMC: 7745522. DOI: 10.1136/jitc-2020-001472.


Introduction to Multiparametric Flow Cytometry and Analysis of High-Dimensional Data.

Sun J, Kroeger J, Markowitz J Methods Mol Biol. 2020; 2194:239-253.

PMID: 32926370 PMC: 7868168. DOI: 10.1007/978-1-0716-0849-4_13.


From Bivariate to Multivariate Analysis of Cytometric Data: Overview of Computational Methods and Their Application in Vaccination Studies.

Lucchesi S, Furini S, Medaglini D, Ciabattini A Vaccines (Basel). 2020; 8(1).

PMID: 32244919 PMC: 7157606. DOI: 10.3390/vaccines8010138.


Optimization in Detection of Antigen-Specific T Cells Through Differentially Labeled MHC Multimers.

Pedersen N, Laske K, Maurer D, Welters M, Walter S, Gouttefangeas C Cytometry A. 2019; 97(9):955-964.

PMID: 31808999 PMC: 7540688. DOI: 10.1002/cyto.a.23942.


References
1.
Walter S, Weinschenk T, Stenzl A, Zdrojowy R, Pluzanska A, Szczylik C . Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival. Nat Med. 2012; 18(8):1254-61. DOI: 10.1038/nm.2883. View

2.
Lee J, Spidlen J, Boyce K, Cai J, Crosbie N, Dalphin M . MIFlowCyt: the minimum information about a Flow Cytometry Experiment. Cytometry A. 2008; 73(10):926-30. PMC: 2773297. DOI: 10.1002/cyto.a.20623. View

3.
Whelan J, Dunbar P, Price D, Purbhoo M, Lechner F, Ogg G . Specificity of CTL interactions with peptide-MHC class I tetrameric complexes is temperature dependent. J Immunol. 1999; 163(8):4342-8. View

4.
Welters M, Gouttefangeas C, Ramwadhdoebe T, Letsch A, Ottensmeier C, Britten C . Harmonization of the intracellular cytokine staining assay. Cancer Immunol Immunother. 2012; 61(7):967-78. PMC: 3378841. DOI: 10.1007/s00262-012-1282-9. View

5.
Wooldridge L, Lissina A, Cole D, van den Berg H, Price D, Sewell A . Tricks with tetramers: how to get the most from multimeric peptide-MHC. Immunology. 2009; 126(2):147-64. PMC: 2632693. DOI: 10.1111/j.1365-2567.2008.02848.x. View